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Objective. To study the short term results of combined peroperative foam sclerotherapy (PFS) and surgical treatment for
recurrent varicose veins.
Methods. PFS was used to treat 129 limbs with recurrent varices: 100 great saphenous (GSV), 29 small saphenous veins
(SSV). Foam was prepared with 1% polidocanol mixed with 4 times its volume of air. The 100 GSVs comprised 28 trunks
directly connected with the femoral vein, 28 connected to a lymph node venous network, 11 associated with perforators
and 33 isolated trunks. The 29 SSVs comprised 4 trunks directly connected to the popliteal vein, 7 isolated trunks, 15
popliteal perforators and 3 recanalisations after SSV stripping. All operations included phlebectomies. In twenty limbs
re-ligation of the SFJ and 4 SPJs was carried out. All were performed under local anaesthesia in an ambulatory setting.
Patients were assessed clinically and by colour duplex ultrasound after 3 and 40 days follow-up.
Results. 120 patients (93%) showed complete obliteration of saphenous trunks, junctions and varices. The 9 incomplete
obliterations were 3 venous recanalisations in the SSV compartment and 6 perforators (4 popliteal and 2 femoral). Two
asymptomatic deep venous thromboses were detected by colour duplex 3 days after operation.
Conclusion. PFS facilitates surgical treatment of recurrent varicose veins. There is a small risk of post-operative deep vein
thrombosis.
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sclerotherapy.Introduction
Foam sclerotherapy has become widely used in recent
years and one randomised study has found that the
medium term outcome is similar to that of surgery.1
It has been shown that foam sclerosants are more
effective than the same volume of liquid sclerosant
of similar strength.2 There is a European consensus
that foam sclerotherapy may be carried out safely
and effectively for the management of varicose veins,
although a wide range of strategies is currently
employed for the use of foam.3,4
The modern evolution of varicose vein surgery has
been towards less traumatic techniques. However,
surgery for recurrence unfortunately often necessi-
tates aggressive dissection or inadequate treatment
may result.5 Foam sclerotherapy may play a role in
the management of recurrent varicose veins by
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Since 2001 we have used peroperative foam sclero-
therapy (PFS) to complete the more invasive parts of
the surgical procedures. In particular we have used
PFS instead of stripping or re-ligation of recurrent
junctions with the aim of minimising the extent of dis-
section. We consider that it is undesirable to extend
the duration of treatment by using postoperative
sclerotherapy and have aimed to treat all aspects of re-
current varices in a single treatment. A previous
study6 demonstrated that foam sclerotherapy could
be used for about 30% of the patients undergoing
redo surgery.
The main advantage of using foam sclerotherapy
during surgery is the opportunity to introduce the
sclerosant directly into the recurrent varices, trunk
or junction under direct vision. If no vein is readily ex-
posed surgically, an injection under ultrasound guid-
ance may be used instead. This improves on what
may be achieved by surgery in two ways. Firstly,
veins which are difficult or impossible to manage
surgically can be treated, including deeply locatederved.
620 D. Creton and J. F. Uhlvenous networks or recurrence within the saphenous
compartment as well as residual saphenous trunks.
Secondly complex networks of veins in the pudendal
region or femoral lymph node are readily managed
without the risks normally associated with surgery.
The risk of damage to nearby nerves and lymphatics
is reduced by this strategy.
Material and Methods
Patients
Between June 2003 and April 2005, 129 unselected pa-
tients underwent foam sclerotherapy during surgery
for varicose vein recurrence. Of these, only 19 had
been previously operated on by the same surgeon
(DC), 91 had been operated on by other surgeons
and no data was recorded for the remainder. There
were 105 women (81%) and 24 men (19%); only one
leg was treated in each patient (81 left sides and
48 right sides). The mean age was 55 years (range
29e76). Limbs were assigned to the appropriate
CEAP classification as well as the REVAS5 additions
to CEAP. These data are shown in Tables 1e3.
Venous duplex ultrasound examination was car-
ried out with the patients in a standing position (Gen-
eral Electric Kretz Expert 730, 7/13 MHz transducer,
78457 Ve´lizy, France). Reflux was elicited by a manual
calf compression-release manoeuvre. Reflux exceed-
ing 0.5 seconds was considered significant. The
diameter and the length of the incompetent communi-
cation between the deep and the superficial system
was recorded along with the location, length and
diameter of the incompetent residual saphenous
trunk. The aim of ultrasound investigation was to
select the venous segments where foam sclerotherapy
was preferred since surgical treatment may have
resulted in risks to adjacent structures or been
incomplete.
Prior to treatment all patients gave their informed
consent to the proposed treatment and follow-up.
Table 1. CEAP classification of the patients treated by surgery and
PFS
CEAP « C » Class N %
C1 0 0.0%
C2 96 74.4%
C3 15 11.6%
C4a 14 10.9%
C4b 2 1.6%
C5 0 0.0%
C6 2 1.6%
Total 129 100%Eur J Vasc Endovasc Surg Vol 33, May 2007Immediately before surgery a further ultrasound
examination was performed (Esaote AU4 Idea, Le
Perreux, France, 10 MHz transducer) to identify the
best points for the injection of foam.
Surgery was performed under tumescent local an-
aesthesia or femoral block in an ambulatory setting.
The aim of the operation was the closure of incompe-
tent communications between the deep and superfi-
cial venous system combined with the removal (or
closure) of incompetent residual trunks and the abla-
tion of varices. Varices were generally considered best
managed by phlebectomy, whereas residual incom-
petent trunks, perforators and inguinal or popliteal
recurrences were considered for either surgical
treatment or foam sclerotherapy according to the
expected technical difficulty of surgery. Any part
of the treatment which was attempted surgically
but required excessively aggressive dissection was
managed by foam sclerotherapy. The number of
phlebectomy incisions, corresponding to the extent
of varices treated, was recorded.
Sclerosant foam was made with 1% polidocanol
(Aetoxisclerol, Kreussler, Germany) using the
Table 2. Classification of the patients treated by surgery and foam
according to the CEAP clinical components
Presence of N %
Teliangiectasias 129 100%
Varicose veins 129 100%
Venous oedema 23 17.8%
Inflammation or pigmentation 18 13.9%
Lipodermatosclerosis or white atrophy 2 1.6%
Healed ulcer 0 0.0%
Active ulcer 2 1.6%
Table 3. Classification of patients according to the REVAS system
N %
Topographical
Groin 52 40.3
Thigh 107 82.9
Popliteal fossa 43 33.3
Lower leg 122 94.6
Source
No source 12 0.9
Pelvic abdominal 28 22.2
Sapheno-femoral junction 48 37.2
Thigh perforator 29 22.4
Sapheno-popliteal junction 19 14.7
Popliteal perforator 6 4.6
Gastrocnemiusl veins 0 0
Lower leg perforator 1 0.8
Saphenous trunk
Above knee great saphenous trunk 68 52.7
Below knee great saphenous trunk 21 16.3
Small saphenous vein 11 8.5
No 43 33.3
621Peroperative Foam Sclerotherapy for Recurrent VaricesTessari method.7 Two ml of Polidocanol were mixed
with four times the volume of air (8 ml) to produce
10 ml foam. Foam was made during the operation
immediately before injection.
After foam injection local compression was applied
over treated veins for one minute, as long as this did
not hinder ultrasound imaging of the limb. The foam
volume injected was 2e4 ml for the SSV and 4e6 ml
for the GSV. Although the risk of skin necrosis after
foam is small, the vein or trunk in which foam had
been injected was always ligated to minimise extra-
vasation. Inguinal compression was performed to
prevent the foam from entering the femoral vein
(compression of the saphenous femoral junction dur-
ing foam injection into the saphenous trunk:
Cloutier’s Manoeuvre). The limb was raised in
order to facilitate distal progression of foam and to
minimise passage of foam into the deep venous
system.
The technique of foam introduction was dependant
on the location and topography of the network to be
treated:
The injection of any ‘‘lymph node venous network’’,
also known as the ‘‘dystrophic venous network of the
groin’’,8 was performed in a downward direction un-
der visual control by direct needle puncture through
the redo incision in the groin (Fig. 1). Deep injections
at the bottom of the incision were facilitated by using
a long 22 g needle and a 25 cm extension tube. Distal
to the groin incision ultrasound-guided puncture
(needle or Butterfly) or injection through a long
catheter with its tip located at the proximal end of
the residual trunk were used. Surgical intervention
was used for recurrence at the SFJ where the diameter
Fig. 1. GSV injection can be performed downwards under
visual control by direct puncture through a surgical incision
or upwardly by means of a catheter or by an ultrasound-
guided puncture.was greater than 3 mm. Two types of disconnection of
the residual SFJ were carried out: ligation-section with
patch interposition or ligation only using a non-
absorbable suture material. In order to avoid the risk
of common complications of re-do surgery in the
groin (neovascularization, neurological and lymphatic
lesions) we chose to carry out a lateral approach in the
groin to avoid areas of previous dissection and used
binocular loupes.9 The aim of this ligation was to
avoid passage of foam into the femoral vein during in-
jections near the groin. In cases where there was
a long residual stump at the SPJ, flush ligation with
the popliteal vein was carried out.
Recanalisation of venous pathways such as previously
stripped great and small saphenous veins were
treated by ultrasound guided injection with foam.
These were invariably complex tangled networks of
veins lying in the saphenous compartment of the
previously stripped vein. Effective surgical treatment
of these veins is impossible (Fig. 2).
Sclerosis of a residual saphenous trunk was easily
carried out by inserting a long catheter, (angiocath
4F, Super Torque, Johnson&Johnson Company, Cordis
Europa NV, Oosteinde 8, NL-9301 L J Roden) through
the part of the trunk that had been exposed during
phlebectomy. When the residual trunk could not be
reached by phlebectomy, sclerosis was performed
under ultrasound guidance with a 22 G needle or
a Butterfly (Microflex, Vygon BP7, 95440 F-Ecquen)
equipped with an extension tube. This allowed aspira-
tion and saline rinsing manoeuvres without moving
the needle. During the foam injection by means of
a catheter, the correct positioning of the tip of the cath-
eter was achieved by ultrasound imaging. Usually the
catheter was visible with a 10 or 13 MHz probe. Saline
injection was use to facilitate visualisation of the vein
around the catheter The catheter was filled with saline
before insertion into the vein to facilitate blood flow
into the catheter and to minimise injection of air
Fig. 2. Recanalisation after stripping between two portions
of a residual trunk on the small saphenous vein.Eur J Vasc Endovasc Surg Vol 33, May 2007
622 D. Creton and J. F. Uhlbubbles from the catheter. The foam injection was
usually performed as the catheter was pulled out.
Perforator injection was carried out either by direct
puncture or indirectly through a long catheter where
the perforator was connected to a residual saphenous
trunk. When the perforator was connected with vari-
cose veins that could be accessed by a phlebectomy
incision, foam injection was easily performed through
a small 20 G catheter (Optiva 2 Medex Medical Ltd,
Rossendale, BB4 4PW, UK).
Post operative compression was achieved by
application of two class II French stockings
(2 20¼ 40 mm Hg) for two days and then by one
stocking for 2 weeks. Bandages were not used.
Patients could choose either ambulatory surgery with
return home on the same day as treatment
or hospitalization which was more appropriate for
patients living alone or where no one was available
to escort them home. No restriction of daily activities
was advised. No analgesic drugswere prescribed post-
operatively although patients were allowed to take
proprietary drugs obtained without prescription
from a pharmacy. Thrombopropylactic injections of
enoxaparine 20 mg (Love´nox, Sanofi Aventis,
France) were given to all patients by a nurse at home
for 8 days.
The patients were examined 3 days and 40 days
following PFS. Clinical and duplex ultrasound inves-
tigations were performed on each occasion. The aim
these examinations was to assess the deep veins for
the presence of deep venous thrombosis (DVT) and
to evaluate efficacy of sclerosis of veins. Well estab-
lished efficiency criteria were used3 and included
the presence of an incompressible vein, absence of re-
flux on colour Doppler when performing a Valsalva
manoeuvre and calf compression/release manoeuvre.
Extension of thrombophlebitis into deep veins, possi-
ble residual reflux, haematomas and residual varices
were also sought.
As the follow-up period of 40 days was very short
the patients were asked to answer only one question:
‘‘Are you feeling better, the same or worse than
before’’. Clinical evaluation for the development of
new varices was not done since the very early stage
of follow-up was too early for any further varices to
be clinically apparent.
Results
One hundred recurrences in the GSV territory and 29
in the SSV territory were treated. All operations con-
sisted of phlebectomies with or without inguinal or
popliteal fossa redo operations. The mean number of
phlebectomy incisions was 24.3 (range 8e82).Eur J Vasc Endovasc Surg Vol 33, May 2007Distribution of the type of PFS
Recurrence after previous GSV surgery represented
most of the indications. The type of sclerotherapy de-
pended on the anatomical type of these 100 cases
(Fig. 3).
There were 28 residual trunks directly connected
with the femoral vein via a residual sapheno-
femoral junction. Among these, only 16 inguinal
redo operations were performed before the injection,
in order to divide (n¼ 8) or ligate with a non absorb-
able suture (n¼ 8) the new communication
between the femoral vein and the varices. The 12 re-
maining trunks underwent foam injection only with-
out surgical disconnection.
Twenty-eight residual trunks connected with the
femoral vein through new vessels, ‘‘lymph node ve-
nous network’’ or sometimes without any clear con-
nection with the deep system, were sclerosed with
a catheter introduced from below.
Thirty-three isolated residual trunks without any
connection with the deep venous system were treated
by foam injection carried out through a catheter or by
direct needle puncture.
Eleven long thigh perforators with small diameters
connected to a residual trunk were injected through
a catheter or by direct puncture.
The 29 recurrences after SSV surgery were treated
according to the type of recurrence (Fig. 4):
Fifteen popliteal fossa perforators were treated
with foam injection by direct puncture without redo
operation in the popliteal fossa.
8 8 12 28 33 11
Peroperative sclerotherapy
in GSV recurrence
N=100
61 residual trunks without SFJ28 residual trunks with SFJ
Fig. 3. Distribution of the 100 operation for GSV recurrence:
28 residual trunks connected to the femoral vein through
a residual sapheno-femoral junction (SFJ) (16 underwent
redo surgery in the groin. 8 ligation-section and 8 ligation
only). 61 residual trunks (33 isolated and 28 connected to
the GSV) and 11 perforators. Arrows indicate the location
of foam injection.
623Peroperative Foam Sclerotherapy for Recurrent VaricesFour residual trunks directly connected with the
popliteal vein via a long residual stump were
sclerosed during operation just after flush ligation of
the long residual stump.
Three cases of SSV recanalisation were sclerosed by
direct puncture.
In 7 cases, a residual SSV without any connection
with the popliteal vein was injected via a long catheter.
Results at follow-up
No patient presented with either any visual distur-
bance, migraine, neurological complications or local
complications such as necrosis or cutaneous matting.
No significant post-operative complication occurred
following surgical re-ligation of the SFJ or SPJ. There
was no case of lymphatic leak and no patient reported
symptoms suggestive of nerve injury. No case of
wound infection was encountered.
Fourteen patients failed to attend for the 3 day fol-
low-up but all attended at 40 days. Clinical results at
40-dayswere excellent. Varicose veinswere completely
eliminated improved quality of life; 94 patients felt
better, 25 felt similar and 6 felt worse as a consequence
of subcutaneous postoperative haematomas, 4 no data.
Two thighperforators (out of 11) and fourperforators
in the popliteal fossa (out of 15) were not completely
closed. Three venous recanalisations in the saphenous
compartment after stripping of the SSV were not
completely closed. Obliteration of treated veins was
complete in 92% of patients at the 40-day follow-up.
Two clinically asymptomatic deep vein thromboses
were discovered at the first ultrasound examination
4 15 7 3
N=29
Peroperative sclerotherapy
in SSV recurrence
Fig. 4. Distribution of the 29 PFS in SSV recurrence: 4 resid-
ual trunks connected to a long residual stump (redo surgery
in popliteal fossa), 15 perforators in the popliteal fossa, 7
isolated residual trunks and 3 recanalisations in the saphe-
nous compartment. Arrows indicate the location of foam
injection.on day 3. Partial thrombosis of the femoral vein aris-
ing from the inguinal connection of a sclerosed saphe-
nous trunk occurred in one case. This residual trunk
was one of 12 directly connected with the femoral
vein by a residual stump. This trunk was injected
without prior ligation or disconnection. The second
was a gastrocnemius vein thrombosis after the sclero-
sis of a SSV residual trunk (one of 7). These 2 post-
operative thromboses were successfully treated by
a course of low molecular weight heparin.
Discussion
At the 40 day follow-up a small number of veins were
found to have recanalised despite treatment by foam
sclerotherapy. Our aim of avoiding the need for
post-operative treatment for residual veins was there-
fore not completely achieved. The percentage of com-
plete obliterations after injection (92%) corresponds to
the percentage mentioned in the literature regarding
sclerotherapy for primary varices10,11,12 and for recur-
rence.13 The 9 cases of incomplete obliteration proba-
bly result from inadequate filling of veins with foam,
perhaps due to our limited experience of this tech-
nique and our fear of causing damage to the deep
veins by injecting an excessive volume.
The three recanalisations that occurred following
treatment of recurrences in the track of the stripped
SSV involved large veins 6 or 7 mm in diameter. These
probably required much more foam than we injected.
Similarly, large popliteal perforators or thigh perfora-
tors connected directly to the deep veins (femoral or
popliteal), were not completely filled to avoid excess
foam reaching the deep veins. These types of perfora-
tors are often subjected to high venous pressures
increasing the tendency to reopen. Successful
treatment of these vein types may require better
emptying of the veins by limb elevation and injection
of larger volumes of sclerosant foam.
The peroperative use of foam makes it more effi-
cient, because the trunks are first surgically discon-
nected. Since there is no blood flow following
ligation the foam is neither displaced nor diluted, en-
hancing the efficacy of treatment. Combined phlebec-
tomies considerably reduce the risk of superficial
venous thrombosis in areas treated by sclerotherapy.
The efficiency of foam sclerotherapy is also strongly
influenced by phlebectomies which leads to abolition
of reflux in the residual saphenous trunks.
In this study, we observed two cases of DVTwhich
where probably due to the fact that most patients did
not get up and walk immediately after sclerotherapy
or got up only after a thirty-minute rest period. NoEur J Vasc Endovasc Surg Vol 33, May 2007
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level, a single thrombosis occurred for a trunk directly
connected to the femoral vein. This appeared to arise by
extension of thrombus from the saphenous trunk.
Surgical exclusion should have been performed first.
Thromboembolic risk seems to increase when scle-
rosis is performed per-operatively probably due to an
activation of coagulation factors during surgery14,15,16
No data is available concerning the DVT risks after
varicose vein surgery carried out under local anaes-
thesia in ambulatory setting. Clinically apparent
thromboembolic complications occurred in 0.43% of
4206 patients treated surgically for varicose veins un-
der loco-regional anaesthesia without LWMH prophy-
laxis.17 In this series we used post-operative LMWH
prophylaxis in the hope of minimising the risk of
DVT. This strategy is not unanimously accepted4 since
it may impair the efficacy of sclerotherapy.18
This clinical series shows the feasibility of using
foam sclerotherapy during surgical treatment for re-
current varices. This led to a high rate of obliteration
of residual saphenous trunks, recurrent varices and
recanalisations of previously stripped veins. We con-
sider that it is less hazardous than aggressively pursu-
ing technically difficult surgical approaches which
may result in lymphatic leaks or nerve injury. Two
cases of DVT in our series show that even though
foam sclerotherapy minimises the extent of surgery
for recurrent varicose veins, thrombotic complications
may arise despite prophylactic heparin treatment.
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